Jane E. Beggs

Founded in 2004 by Barr Dolan, Donald Harrison and Fred Schwarzer, Charter Life Sciences is a venture capital firm headquartered in Santa Clara, California

Minimally Invasive Devices, Inc. develops laparoscopic visualization tools and systems. It offers FloShield Air, a vortex barrier technology that provides a continuous flow of dry carbon dioxide gas over the tip of the scope, instantly defogging it while continuously shielding it from condensation, debris, and smoke. It also offers FloShield Plus, an intra-operative flush that can be used to clean a scope if it gets dirty during surgery. The company was founded by Wayne L. Poll and Jodi Wolfe in 2006 and is headquartered in Columbus, OH.

Charter Venture Capital (Charter Venture) is a venture capital firm founded in 1982. The firm is headquartered in Palo Alto, California.

Peregrine Ophthalmic Pte Ltd. develops and manufactures nanomedicine products. It offers liposomal latanoprost an extended release drug delivery solution for glaucoma. The company was founded by Freddy Yin Chiang Boey, Subbu S. Venkatraman, and Tina Wong in 2013 and is headquartered in Singapore.

Singapore-MIT Alliance for Research & Technology engages in research and development in life sciences. The company was founded in 2007 and is headquartered in Singapore.

DSO National Laboratories is Singapore's national defense research and development organization. DSO has been developing advanced defense and weapon systems for the Singapore Armed Forces for the past 5 decades. The non-profit company is based in Singapore, Singapore. It also extends its defense R&D capabilities to support homeland security. With over 1,600 research scientists and engineers, DSO investigates emerging technologies, matures promising ones, and integrates them into innovative system concepts to meet Singapore's defense and security needs. Founded in 1972, the CEO is Cheong Chee Hoo.

Institute of Materials, Minerals & Mining Ltd. is an organization that provides links for getting in touch with the team and departments at iom3. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. The British company has developed the first cardiac implant made from graphene, according to researchers led by Northwestern University and the University of Texas at Austin, USA.

Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia.

Health Fidelity, Inc. operates as a holding company that provides cloud-based healthcare natural language processing (NLP) and unstructured data management solutions. Its platform features NLP engine, data acquisition, retrospective and prospective risk adjustment, compliance support, comprehensive analytics, and physician integration. The company was founded by Daniel J. Riskin, Anand Shroff, Brian Alex Dummett and Yan Chow in 2011 and is headquartered in San Mateo, CA.

Mirabilis Medica, Inc. engages in the development of non-invasive ultrasound technology for treatment of uterine fibroids. The company was founded in by Michael P. H. Lau, Alexander Lebedev and Shahram Vaezy August 2004 and is headquartered in Bothell, WA.

GCA Law Partners LLP is based in Mountain View, CA. GCA Law Partners LLP is a law firm that has been providing legal services to the business community since 1988. The company was founded by Fred M. Schwarzer.

S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award.

Eighteen48 Partners Ltd (Eighteen48 Partners) is a private equity firm founded in 2019 by Tarek Fuad AbuZayyad and Julien Bernard Marie Sevaux. The firm is headquartered in London, United Kingdom.

Part of UBS Group AG, UBS Warburg Asia Ltd. is a national commercial bank. The company is based in Hong Kong, Hong Kong.

DCP Management Pte Ltd. provides investment and advisory services. It acts as a private equity advisory firm which provides asset management and fund managers services. The company is headquartered in Singapore.

Part of Abbott Laboratories, Abbott Vascular, Inc. is a company that manufactures cardiac and vascular care systems. The company is based in Abbott Park, IL.

Crystalline Medical, Inc. develops solutions for the rapidly growing image-guided surgery market. Its technology provides for a forward-viewing, image-guided interventional probe that seeks to significantly improve both the safety and efficacy of millions of procedures per year in the areas of interventional radiology, cardiology, interventional oncology, pulmonology, and urology. The company was founded by Theodore P. Abraham in 2012 and is headquartered in Baltimore, MD.

Part of Medtronic Plc, Progressive Angioplasty Systems, Inc. is a company that makes and develops stents and stent technologies. The company is based in Menlo Park, CA. The company was founded by Frank Litvak, Frank Litvack. Progressive Angioplasty Systems was acquired by United States Surgical Corp. on September 23, 1997 for $150 million.

EDB Investments Pte Ltd (EDB Investments) is a Venture Capital firm founded in 1991. The firm is headquartered in Singapore.

Trireme Medical LLC develops and manufactures novel stent technology for the treatment of atherosclerotic disease. It offers coronary stent systems, balloon catheters, and percutaneous transluminal coronary angioplasty balloon catheters for the treatment of coronary and peripheral arterial disease. The company is focused on the United States and the emerging Asian markets. The company was founded by Eitan Konstantino and Feld Tanhum in 2005 and is headquartered in Pleasanton, CA,